C-U5MXNeuroTrack
digital cognitive screening, cognitive assessment, eye-tracking research
diagnostics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-U5MX
C-U5MXC-U5MXdigital cognitive screening, cognitive assessment, eye-tracking research
0-100 chain-logic scale · 15 dimensions · scored on public evidence
NeuroTrack digital cognitive screening, cognitive assessment, eye-tracking research
Neurotrack develops FDA-registered digital tools for cognitive screening and care, focused on detecting cognitive decline earlier and improving outcomes for patients with Alzheimer's and related dementias. Its platform provides quick cognitive baselines, instantly scored DSM-5-aligned results, functional questionnaires, personalized care plans, and EHR integration. The company states that its solutions are used by 15,000+ clinicians and supported by peer-reviewed publications and funding from organizations including the NIA and the Gates Foundation.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
NeuroTrack — Far from goals · Lower middle. Derived deterministically from 5 extracted project(s). Most-advanced status: exploratory. Band: far. Modifiers: +5 depth (3 programs at exploratory).…
Source: Deterministic